COVID-19 in Nursing Homes 2020 and 2021

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

258 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-31

Study Completion Date

2021-04-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To describe the effect on mortality in nursing home facilities during three separate equally long periods during the pandemic and more specifically to analyse the effect on mortality of improved preventive routines and vaccination.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

COVID-19 in Home Healthcare

NCT04642196

Covid19

COMPLETED

Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents

NCT04740658

Covid19

COMPLETED

Patterns of Antibiotics Resistance

NCT06696859

Antibiotics Resistance

NOT_YET_RECRUITING

2-year Mortality After COVID-19 in Nursing Home Residents

NCT06468761

Covid19

COMPLETED

Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection

NCT04849585

Covid19

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retrospective descriptive cohort study in Östergötland County Council, Sweden comprising 136 nursing home facilities with a possibility to host 4500 residents. All residents in any of these NHs who had a laboratory confirmed COVID-19 diagnosis between March 2020 to April 2021 and who died within 30 days after the verified diagnosis are included. The study is undertaken as a retrospective record review. From the records patient-level data on demographic variables, clinical signs, comorbidity, performance status, and cause of death are collected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Comorbidities and Coexisting Conditions Frailty Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All residents in any of 136 nursing homes in Östergötland County Council, Sweden who had a laboratory confirmed COVID-19 diagnosis and who died within 30 days after the verified COVID-19 were included in three separate periods: First period from March 31 to June 30 2020; second period from October 15 2020 to January 15 2021; third period from January 16 to April 18 2021.